Leading the way to safer medication
 Crosscheck  Recommender

Nimbex Injection 2mg/ml (2012)

Active ingredients: Cisatracurium

Product Name and Form

Nimbex 2mg/ml solution for injection/infusion.

Pharmaceutical form

Solution for injection/infusion.

Colourless to pale yellow or greenish yellow solution. Practically free from visible particulate matter.

Qualitative and Quantitative Composition

Cisatracurium 2mg as cisatracurium besilate 2.68mg per 1ml.

One ampoule of 2.5ml contains 5mg of cisatracurium.

One ampoule of 5ml contains 10mg of cisatracurium.

One ampoule of 10ml contains 20mg of cisatracurium.

One ampoule of 25ml contains 50mg of cisatracurium.

For excipients, see Section 6.1.

Chemical substance
Description
Cisatracurium

Cisatracurium is an intermediate-duration, non-depolarising benzylisoquinolinium skeletal muscle relaxant.

List of excipients

Benzene sulfonic acid solution 32% w/v
Water for injections

Pack sizes and Marketing

Nimbex 2mg/ml solution for injection/infusion.

2.5ml in ampoule (glass): box of 5

5ml in ampoule (glass): box of 5

10ml in ampoule (glass): box of 5

25ml in ampoule (glass: box of 2

Type I, clear, neutral glass ampoules.

NOT ALL PACK SIZES MAY BE MARKETED

Marketing authorization holder
Authorization dates

The Wellcome Foundation Limited
980 Great West Road
Brentford
Middlesex
TW8 9GS
United Kingdom

Trading as:

GlaxoSmithKline UK
Stockley Park West
Uxbridge
Middlesex
UB11 1BT

Date of first authorisation: 07 August 1995

Date of last renewal: 09 August 2010

Marketing authorization number:

PL 00003/0364